Literature DB >> 25928305

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez.   

Abstract

Entities:  

Year:  2015        PMID: 25928305      PMCID: PMC4415798          DOI: 10.1371/journal.pone.0127133

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The tenth author’s name is spelled incorrectly. The correct name is: Alvaro Moreno-Aspitia. The Academic Editor field is missing from the published paper. The name of the Academic Editor is: Aamir Ahmad, Wayne State University School of Medicine, United States.
  1 in total

1.  Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Authors:  Brian M Necela; Jennifer A Crozier; Cathy A Andorfer; Laura Lewis-Tuffin; Jennifer M Kachergus; Xochiquetzal J Geiger; Krishna R Kalari; Daniel J Serie; Zhifu Sun; Alvaro Moreno-Aspitia; Alvaro Moreno Aspita; Daniel J O'Shannessy; Julia D Maltzman; Ann E McCullough; Barbara A Pockaj; Heather E Cunliffe; Karla V Ballman; E Aubrey Thompson; Edith A Perez
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

  1 in total
  4 in total

1.  Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer.

Authors:  Alexandra Sneider; Rahul Jadia; Brandon Piel; Derek VanDyke; Christopher Tsiros; Prakash Rai
Journal:  Oncomedicine       Date:  2017-01-01

2.  Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy.

Authors:  Yang Xia; Xiongwei Deng; Minjun Cao; Sha Liu; Xiaofei Zhang; Xiangqian Xiao; Sisi Shen; Qin Hu; Wang Sheng
Journal:  RSC Adv       Date:  2018-04-12       Impact factor: 3.361

Review 3.  Targeting folate receptor alpha for cancer treatment.

Authors:  Anthony Cheung; Heather J Bax; Debra H Josephs; Kristina M Ilieva; Giulia Pellizzari; James Opzoomer; Jacinta Bloomfield; Matthew Fittall; Anita Grigoriadis; Mariangela Figini; Silvana Canevari; James F Spicer; Andrew N Tutt; Sophia N Karagiannis
Journal:  Oncotarget       Date:  2016-08-09

4.  Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.

Authors:  Ornella I Selmin; Micah G Donovan; Bethany Skovan; Gillian D Paine-Murieta; Donato F Romagnolo
Journal:  Int J Oncol       Date:  2019-01-15       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.